In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more accurate.

For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies.

Frailty scores alone (mFI-5, CCI) are poor predictors of intensive care unit (ICU) admission or prolonged hospital stay in ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for chemotherapy in certain patients with NSCLC.

Ravindra Uppaluri, MD, PhD, discusses findings from the KEYNOTE-689 trial in adult patients with resectable, locally advanced head and neck squamous cell carcinoma.

Virtual consultations hold the potential to transform patient care; however, their capacity to fully replace face-to-face interactions remains uncertain. ten Haaft and colleagues present findings from ...

A video consultation between patient and surgeon is just as good as a physical visit to the outpatient clinic to discuss a major operation. This is evident from research by Amsterdam UMC, demonstrated ...

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

FDA has approved perioperative pembrolizumab for resectable head and neck squamous cell carcinoma, but do patients need ...

Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.